BioLife Cash from 2010 to 2025

BLFS Stock  USD 25.83  0.97  3.62%   
BioLife Solutions Cash yearly trend continues to be comparatively stable with very little volatility. Cash is likely to outpace its year average in 2025. Cash is the total amount of money in the form of currency that BioLife Solutions has in its possession. This includes all bills, coins, and funds in bank accounts. View All Fundamentals
 
Cash  
First Reported
1989-06-30
Previous Quarter
24 M
Current Value
95.4 M
Quarterly Volatility
20.7 M
 
Oil Shock
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check BioLife Solutions financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among BioLife Solutions' main balance sheet or income statement drivers, such as Interest Expense of 755 K, Selling General Administrative of 38.5 M or Total Revenue of 86.4 M, as well as many indicators such as Price To Sales Ratio of 13.81, Dividend Yield of 0.0014 or PTB Ratio of 3.26. BioLife financial statements analysis is a perfect complement when working with BioLife Solutions Valuation or Volatility modules.
  
Check out the analysis of BioLife Solutions Correlation against competitors.
For more information on how to buy BioLife Stock please use our How to Invest in BioLife Solutions guide.

Latest BioLife Solutions' Cash Growth Pattern

Below is the plot of the Cash of BioLife Solutions over the last few years. Cash refers to the most liquid asset of BioLife Solutions, which is listed under current asset account on BioLife Solutions balance sheet and usually includes currency, coins, checking accounts, and not deposited checks received from BioLife Solutions customers. The amounts must be unrestricted with restricted cash listed in a different BioLife Solutions account. It is the total amount of money in the form of currency that a company has in its possession. This includes all bills, coins, and funds in bank accounts. BioLife Solutions' Cash historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in BioLife Solutions' overall financial position and show how it may be relating to other accounts over time.
Cash10 Years Trend
Slightly volatile
   Cash   
6.4M90.569.919.435.495.4100.1303%-23%-72%82%169%5%100%
       Timeline  

BioLife Cash Regression Statistics

Arithmetic Mean29,401,432
Geometric Mean5,450,081
Coefficient Of Variation127.67
Mean Deviation30,690,339
Median9,938,394
Standard Deviation37,537,218
Sample Variance1409T
Range100.1M
R-Value0.78
Mean Square Error588.1T
R-Squared0.61
Significance0.0004
Slope6,160,020
Total Sum of Squares21135.6T

BioLife Cash History

2025100.2 M
202495.4 M
202335.4 M
202219.4 M
202169.9 M
202090.5 M
20196.4 M

Other Fundumenentals of BioLife Solutions

BioLife Solutions Cash component correlations

About BioLife Solutions Financial Statements

BioLife Solutions shareholders use historical fundamental indicators, such as Cash, to determine how well the company is positioned to perform in the future. Although BioLife Solutions investors may analyze each financial statement separately, they are all interrelated. The changes in BioLife Solutions' assets and liabilities, for example, are also reflected in the revenues and expenses on on BioLife Solutions' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Cash95.4 M100.2 M
Cash And Short Term Investments104.6 M109.8 M
Change In Cash59.9 M62.9 M
Free Cash Flow5.2 M5.5 M
Begin Period Cash Flow35.4 M37.2 M
Other Cashflows From Financing Activities-175 K-166.2 K
Other Non Cash Items-10.9 M-10.4 M
Total Cash From Operating Activities8.4 M8.9 M
Total Cash From Financing Activities-6.8 M-6.4 M
End Period Cash Flow95.4 M100.2 M
Total Cashflows From Investing Activities-52.3 M-49.7 M
Other Cashflows From Investing Activities58 M60.9 M
Cash And Cash Equivalents Changes96.6 M101.4 M
Cash Flows Other OperatingM1.1 M
Operating Cash Flow Per Share 0.18  0.19 
Free Cash Flow Per Share 0.11  0.12 
Cash Per Share 2.27  2.38 
Capex To Operating Cash Flow 0.38  0.28 
EV To Operating Cash Flow 133.52  140.19 
EV To Free Cash Flow 216.31  227.13 
Price To Operating Cash Flows Ratio 141.85  148.94 
Price To Free Cash Flows Ratio 229.80  241.29 
Cash Ratio 2.91  1.71 
Cash Conversion Cycle 419.66  440.64 
Operating Cash Flow Sales Ratio 0.10  0.11 
Free Cash Flow Operating Cash Flow Ratio 0.62  0.60 
Cash Flow Coverage Ratios 0.33  0.35 
Price Cash Flow Ratio 141.85  148.94 
Cash Flow To Debt Ratio 0.33  0.35 

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for BioLife Stock Analysis

When running BioLife Solutions' price analysis, check to measure BioLife Solutions' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioLife Solutions is operating at the current time. Most of BioLife Solutions' value examination focuses on studying past and present price action to predict the probability of BioLife Solutions' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioLife Solutions' price. Additionally, you may evaluate how the addition of BioLife Solutions to your portfolios can decrease your overall portfolio volatility.
News Freq…Investor S…